Estimation of health risk by using toxicokinetic modelling: A case study of polychlorinated biphenyl PCB153

Journal of Hazardous Materials

Volumn 261, Issue , 2013, Pages 1-10

  Abass, Khaled ^a,c   Huusko, Antti ^a   Nieminen, Pentti ^a   Myllynen, Päivi ^a   Pelkonen, Olavi ^a   Vahakangas, Kirsi ^b   Rautio, Arja ^a  

^a UNIVERSITY OF OULU   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c MENOUFIA UNIVERSITY   (Egypt)

Author keywords

Cancer risk; Hazard quotient; Health outcomes; Toxicokinetic modelling

Indexed keywords

BLOOD CONCENTRATIONS; CANCER RISK; EXPOSURE ASSESSMENT; HAZARD QUOTIENTS; HEALTH OUTCOMES; HUMAN HEALTH EFFECTS; TOXICOKINETIC MODEL; TOXICOKINETICS;

HAZARDS; RISK ASSESSMENT;

HEALTH RISKS;

2,2',4,4',5,5' HEXACHLOROBIPHENYL; LIPID;

BIOACCUMULATION; BIOMONITORING; BLOOD; CANCER; DOSE-RESPONSE RELATIONSHIP; HEALTH IMPACT; HEALTH RISK; INDIGENOUS POPULATION; PCB; POLLUTION EXPOSURE; RISK ASSESSMENT; TOXICITY TEST; TOXICOLOGY; WOMENS HEALTH;

ARTICLE; BODY BURDEN; CANCER RISK; CASE STUDY; HEALTH HAZARD; HUMAN; LIPID BLOOD LEVEL; MODEL; POPULATION; RISK ASSESSMENT; TOXICOKINETICS;

ARCTIC; CANADA; DISKO BAY; GREENLAND; NUNAVIK; NUUK; QUEBEC [CANADA];

ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION; ADD; ADME; AHR; AMAP; ARCTIC MONITORING AND ASSESSMENT PROGRAMME; ARYL HYDROCARBON RECEPTOR; AVERAGE DAILY DOSE; BENCHMARK DOSE LEVEL; BMDL; BMI; BODY MASS INDEX; CANCER RISK; CANCER SLOPE FACTOR; CAR; CONSTITUTIVE ANDROSTANE RECEPTOR; CR; CSF; HAZARD QUOTIENT; HEALTH OUTCOMES; HQ; INTEGRATED RISK INFORMATION SYSTEM; IRIS; LADD; LIFETIME AVERAGE DAILY DOSE; PERSISTENT ORGANIC POLLUTANTS; POPS; PREGNANE X RECEPTOR; PXR; REFERENCE DOSE; RFD; TOXICOKINETIC MODELLING; UNITED STATES ENVIRONMENTAL PROTECTION AGENCY; US-EPA;

ADOLESCENT; ADULT; ENVIRONMENTAL MONITORING; FEMALE; GREENLAND; HUMANS; LIPID METABOLISM; LIPIDS; MIDDLE AGED; MILK, HUMAN; MODELS, BIOLOGICAL; POLYCHLORINATED BIPHENYLS; PREGNANCY; RISK ASSESSMENT; YOUNG ADULT;

EID: 84880993067     PISSN: 03043894     EISSN: 18733336     Source Type: Journal    
DOI: 10.1016/j.jhazmat.2013.07.011     Document Type: Article

References (47)

1. DeRosa C., Richter P., Pohl H., Jones D.E. Environmental exposures that affect the endocrine system: public health implications. J. Toxicol. Environ. Health B 1998, 1:3-26.
2. Sager D.B., Girard D.M. Long-term effects on reproductive parameters in female rats after translactational exposure to PCBs. Environ. Res. 1994, 66:52-76.
3. ATSDR - U.S.Centers for Disease Control (ATSDR) Toxicological Profile for Polychlorinated Biphenyls (PCBs) 2000, http://www.atsdr.cdc.gov/toxprofiles/tp17.pdf.
4. IPCS/WHO Polychlorinated biphenyls: human health aspects. Concise international chemical assessment document 55 2003, http://www.who.int/ipcs/publications/cicad/en/cicad55.pdf (accessed February 2013).
5. Supriyo D., Pramanik S.K., Williams A.L., Dutta S.K. Toxicity of polychlorobiphenyls and its bioremediation. Int. J. Hum. Genet. 2004, 4:281-290.
6. Armitage J.M., Hanson M., Axelman J., Cousins I.T. Levels and vertical distribution of PCBs in agricultural and natural soils from Sweden. Sci. Total Environ. 2006, 371:344-352.
7. Arpiainen S. Transcirptional Regulation of the Hepatic Cytochrome P450 2a5 Gene 2007, Oulu University.
8. Diani-Moore S., Ram P., Li X., Mondal P., Youn D.Y., Sauve A.A., Rifkind A.B. Identification of the aryl hydrocarbon receptor target gene TiPARP as a mediator of suppression of hepatic gluconeogenesis by 2,3,7,8-tetrachlorodibenzo-p-dioxin and of nicotinamide as a corrective agent for this effect. J. Biol. Chem. 2010, 285:38801-38810.
9. Tappenden D.M., Lynn S.G., Crawford R.B., Lee K., Vengellur A., Kaminski N.E., Thomas R.S., LaPres J.J. The aryl hydrocarbon receptor interacts with ATP5α1, a subunit of the ATP synthase complex, and modulates mitochondrial function. Toxicol. Appl. Pharmacol. 2011, 254:299-310.
10. Chu S., Covaci A., Schepens P. Levels and chiral signatures of persistent organochlorine pollutants in human tissues from Belgium. Environ. Res. 2003, 93:167-176.
11. Honkakoski P., Sueyoshi T., Negishi M. Drug-activated nuclear receptors CAR and PXR. Ann. Med. 2003, 35:172-182.
12. Lemaire G., Benod C., Nahoum V., Pillon A., Boussioux A., Guichou J., Subra G., Pascussi J., Bourguet W., Chavanieu A., Balaguer P. Discovery of a highly active ligand of human pregnane X receptor: a case study from pharmacophore modeling and virtual screening to in vivo biological activity. Mol. Pharmacol. 2007, 72:572-581.
13. Kopec A.K., Burgoon L.D., Ibrahim-Aibo D., Mets B.D., Tashiro C., Potter D., Sharratt B., Harkema J.R., Zacharewski T.R. PCB153-elicited hepatic responses in the immature, ovariectomized C57BL/6 mice: comparative toxicogenomic effects of dioxin and non-dioxin-like ligands. Toxicol. Appl. Pharmacol. 2010, 243:359-371.
14. Quantiitative Environmental Risk Analysis for Human Health 2007, Wiley Interscience, New Jersey. R. Fjeld, N. Esienberg, K. Compton (Eds.).
15. USEPA-IRIS United State Environmental Protection Agency - Integrated Risk Information System (IRIS) 2013, http://www.epa.gov/IRIS/ (accessed February 2013).
16. Inoue K., Harada K., Takenaka K., Uehara S., Kono M., Shimizu T., Takasuga T., Senthilkumar K., Yamashita F., Koizumi A. Levels and concentration ratios of polychlorinated biphenyls and polybrominated diphenyl ethers in serum and breast milk in Japanese mothers. Environ. Health Perspect. 2006, 114:1179-1185.
17. Kiviranta H., Hallikainen A., Ruokojärvi P., Rantakokko P., Vartiainen T. PCDD/F, PCB and PBDE levels in Finnish foodstuffs in 2003-2005. Organohalogen Compd. 2006, 68:1898-1901.
18. AMAP AMAP Assessment 2009: Human health in the Actic. Arctic Monitoring and Assessment Pro-gramme (AMAP) Oslo, Norway 2009, xiv:254.
19. Anda E.E., Nieboer E., Dudarev A.A., Sandanger T.M., Odland J.Ø. Associations between maternal blood, cord blood and breast milk levels of different organic and inorganic substances. Data from Food security and Indigenous Peoples in the Russian North; the Chukotka Database. J. Environ. Monit. 2007, 9:884-893.
20. Haddad S., Poulin P., Krishnan K. Relative lipid content as the sole mechanistic determinant of the adipose tissue:blood partition coefficients of highly lipophilic organic chemicals. Chemosphere 2000, 40:839-843.
21. Alcock R.E., Sweetman A.J., Juan C., Jones K.C. A generic model of human lifetime exposure to persistent organic contaminants: development and application to PCB-101. Environ. Pollut. 2000, 110:253-265.
22. Verner M.A., Charbonneau M., Lopez-Carrillo L., Haddad S. Physiologically based pharmacokinetic modeling of persistent organic pollutants for lifetime exposure assessment: a new tool in breast cancer epidemiologic studies. Environ. Health Perspect. 2008, 116:886-892.
23. Kreuzer P.E., Csanady G.A., Baur C., Kessler W., Papke O., Greim H., Filser J.G. 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) and congeners in infants. A toxicokinetic model of human lifetime body burden by TCDD with special emphasis on its uptake by nutrition. Arch. Toxicol. 1997, 71:383-400.
24. Andreas Moser G., McLachlan M.S. The influence of dietary concentration on the absorption and excretion of persistent lipophilic organic pollutants in the human intestinal tract. Chemosphere 2001, 45:201-211.
25. Bois F.Y., Jamei M., Clewell H.J. PBPK modelling of inter-individual variability in the pharmacokinetics of environmental chemicals. Toxicology 2010, 278:256-267.
26. Ritter R., Scheringer M., MacLeod M., Schenker U., Hungerbühler K. A multi-individual pharmacokinetic model framework for interpreting time trends of persistent chemicals in human populations: application to a postban situation. Environ. Health Perspect. 2009, 117:1280-1286.
27. Ritter R., Scheringer M., MacLeod M., Moeckel C., Jones K.C., Hungerbühler K. Intrinsic human elimination half-lives of polychlorinated biphenyls derived from the temporal evolution of cross-sectional biomonitoring data from the United Kingdom. Environ. Health Perspect. 2011, 119:225-231.
28. Kuczmarski R.J., Ogden C.L., Guo S.S., Grummer-Strawn L.M., Flegal K.M., Mei Z., Wei R., Curtin L.R., Roche A.F., Johnson C.L. 2000 CDC growth charts for the United States: methods and development. Vital Health Stat. 2002, 11:1-190.
29. Andersen S., Mulvad G., Pedersen H.S., Laurberg P. Body proportions in healthy adult Inuit in East Greenland in 1963. Int. J. Circumpolar Health 2004, 63:73-76.
30. van der Molen G.W., Kooijman S.A.L.M., Slob W. A generic toxicokinetic model for persistent lipophilic compounds in humans: an application to TCDD. Fundam. Appl. Toxicol. 1996, 31:83-94.
31. Heymsfield S.B., Lohman T.G., Wang Z.M., Going S.B. Human Kinetic 2005, 536. Human Kinetics, Champaign, IL. 2nd ed.
32. Schlummer M., Moser G.A., McLachlan M.S. Digestive tract absorption of PCDD/Fs, PCBs, and HCB in humans: mass balances and mechanistic considerations. Toxicol. Appl. Pharmacol. 1998, 152:128-137.
33. Grandjean P., Budtz-jrgensen E., Barr D.B., Needham L.L., Weihe P., Heinzow B. Elimination half-lives of polychlorinated biphenyl congeners in children. Environ. Sci. Technol. 2008, 18(42):6991-6996.
34. US-EPA Risk Assessment Guidance for Superfund, vol. 1, Human Health Evaluation Manual (Part A), EPA/540/1-89/002 1989, Office of Emergency and Remedial Response, Washington, DC.
35. Kodavanti P.R.S., Ward T.R., Derr-Yellin E.C., Mundy W.R., Casey A.C., Bush B., Tilson H.A. Congener-specific distribution of polychlorinated biphenyls in brain regions, blood, liver, and fat of adult rats following repeated exposure to Aroclor 1254. Toxicol. Appl. Pharmacol. 1998, 153:199-210.
36. AMAP AMAP Assessment Report: Arctic Pollution Issues, Chapter 12: Pollution and Human Health 1998, 775-844. Arctic Monitoring and Assessment Programme, Oslo. J.C.V. Hansen, A. Gilman, V. Klopov, J.O. Odland (Eds.).
37. AMAP AMAP Assessment 2002: Persistent Organic Pollutants (POPs) in the Arctic 2004, xvi:310. Arctic Monitoring and Assessment Programme (AMAP), Oslo, Norway.
38. Deutch B., Hansen J.C. High human plasma levels of organochlorine compounds in Greenland. Regional differences and lifestyle effects. Dan. Med. Bull. 2000, 47:132-137.
39. Semple S.E., Proud L.A., Cherrie J.W. Use of Monte Carlo simulation to investigate uncertainty in exposure modeling. Scand. J. Work Environ. Health 2003, 29:347-353.
40. Kruger T., Ghisari M., Hjelmborg P., Deutch B., Bonefeld-Jorgensen E. Xenohormone transactivities are inversely associated to serum POPs in Inuit. Environ. Health 2008, 7:38.
41. Breivik K., Sweetman A., Pacyna J.M., Jones K.C. Towards a global historical emission inventory for selected PCB congeners - a mass balance approach: 1. Global production and consumption. Sci. Total Environ. 2002, 290:181-198.
42. VKM Risk assessment of non dioxin-like PCBs in Norwegian food. Opinion of the Panel on Contaminants of the Norwegian Scientific Committee for Food Safety 2008, http://www.vkm.no/dav/c29e178d9c.pdf (accessed February 2013).
43. EFSA EFSA 2005, Opinion of the Scientific Panel on Contaminants in the Food Chain on a request from the Commission related to the presence of non dioxin-like polychlorinated biphenyls (PCB) in feed and food. EFSA J. 2005, 284:1-137. http://www.efsa.europa.eu/en/efsajournal/doc/284.pdf (accessed March 2013).
44. USEPA, US Environmental Protection Agency Risk Assessment Guidance for Superfund. Vol. I. Human Health Evaluation Manual (Part A) Interim Final. EPA 540-1-89-002 1989, Office of Emergency and Remedial Response, Washington, DC, http://www.epa.gov/oswer/riskassessment/ragsa/ (accessed February 2013).
45. UESPA, US Environmental Protection Agency (USEPA) Methodology for deriving ambient water quality criteria for the protection of human health. EPA-822-B-00-004 2000, Office of Science and Technology, Office of Water, Washington, DC, http://www.epa.gov/waterscience/criteria/humanhealth/method/complete.pdf (accessed February 2013).
46. Nieminen P., Lehtiniemi H., Huusko A., Vähäkangas K., Rautio A. Polychlorinated biphenyls (PCBs) in relation to secondary sex ratio - a systematic review of published studies. Chemosphere 2013, 91:131-138.
47. Taylor K.W., Novak R.F., Anderson H.A., Birnbaum L.S., Blystone C., DeVito M., Jacobs D., Köhrle J., Lee D., Rylander L., Rignell-Hydbom A., Tornero-Velez R., Turyk M.E., Boyles A.L., Thayer K.A., Lind L. Evaluation of the association between persistent organic pollutants (POPs) and diabetes in epidemiological studies: a national toxicology program workshop review. Environ. Health Perspect. 2013, 121(7):774-783.